Author:
Dragoi, Andrei-Lucian M.
Sub-Category:
Biology / Medicine
Date Published:
October 28, 2020
Keywords:
Oxidative stress, COVID-19,
Abstract:
WORK HYPOTHESIS PROPOSED TO BE CLINICALLY TESTED: Oxidative stress is a very important physiopathological link in most infections, and the strong cytoprotection offered by NRF2-activators dietary supplements (NADS/ANSA) (via NRF2 selective activation) against oxidative stress (demonstrated in vivo and in vitro on various types of cells / tissues / human and non-human organisms) can be effectively reproduced clinically (in vivo, by extrapolation) in the lungs, heart, liver and kidneys of human patients (adults or children) with severe infectious diseases of the lower respiratory tract (including COVID-19, including patients with HIV and/or TB and/or chronic hepatitis B / C / B & D that develop such severe respiratory intercurrences), including in patients with other comorbidities (ADI, hypertension, ICC, CI, etc.), including in the post-acute recovery period. I have firstly launched this hypothesis at the end of February 2020: https://www.researchgate.net/publication/339592997
<<< Back